Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. The firm's segments include Pharmaceutical and Animal Health. Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells its human health vaccines primarily to physicians, wholesalers, distributors and government entities. Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species. The company sells its products to veterinarians, distributors, animal producers, farmers and pet owners.
Follow-Up Questions
What is Merck & Co Inc (MRK)'s P/E Ratio?
The P/E ratio of Merck & Co Inc is 12.4232
Who is the CEO of Merck & Co Inc?
Mr. Robert Davis is the Chairman of the Board of Merck & Co Inc, joining the firm since 2014.
What is the price performance of MRK stock?
The current price of MRK is $82.51, it has increased 0.03% in the last trading day.
What are the primary business themes or industries for Merck & Co Inc?
Merck & Co Inc belongs to Pharmaceuticals industry and the sector is Health Care
What is Merck & Co Inc market cap?
Merck & Co Inc's current market cap is $206.1B
Is Merck & Co Inc a buy, sell, or hold?
According to wall street analysts, 27 analysts have made analyst ratings for Merck & Co Inc, including 7 strong buy, 12 buy, 14 hold, 0 sell, and 7 strong sell
